March 12, 2012

UBS YIELD OPTIMIZATION NOTES INVESTMENT LOSSES

The Soreide Law Group is investigating claims on behalf of investors purchasing UBS Yield Optimization Notes. UBS’ Yield Optimization Notes are also known as reverse convertibles. Reverse convertibles are esoteric structured products based upon the performance of a short put option, or derivative. Reverse convertibles are attractive to investors seeking income because of the above average income the product provides. However, this income product has substantial risk of loss of principal. The income comes from the premium received from the sale of a put on the underlying stock. Surprisingly, UBS does not mandate its registered representatives to perform option suitability analysis or have investors fill out options account forms. As a result, investors, including retirees, without options investing experience can been sold complicated option laden reverse convertibles.
 
UBS is one of several firms that are under investigation by the State of Georgia for improper reverse convertible sales. Georgia securities regulators are not alone, the State of Massachusetts is also investigating how firms are selling reverse convertibles to investors. The SEC is also investigating whether the risks and fees of reverse convertibles were properly disclosed to investors. In addition, the SEC is investigating whether investors overpaid for reverse convertibles. Recognizing potential sales abuses associated with reverse convertibles, FINRA issued Notice to Members 10-09, which was a reminder to firms of their disclosure obligations under NTM 05-59. Members are required to provide balanced risk disclosures to investors purchasing reverse convertibles. In 2011, FINRA began conducting regulatory sweeps to monitor how members were selling reverse convertibles to investors. FINRA has subsequently issued NTM 12-03 which seeks heightened supervision for complex products such as reverse convertibles.
 
If you or a loved on has purchased UBS Yield Optimization Notes or a reverse convertible product call Lars K. Soreide of the Soreide Law Group at 888-760-6552 for a free consultation or visit https://www.securitieslawyer.com.
 
 
S H A R E   T H I S   P O S T

Recent Posts

February 18, 2025
CONCORDE INVESTMENTS SERVICES and Bart Harrison

Soreide Law Group, based in South Florida, has filed a FINRA arbitration on behalf of their client (Claimant) against: CONCORDE INVESTMENTS SERVICES, LLC. (Respondent) The Claimant resides in Southwest Florida and maintained a relationship with CONCORDE INVESTMENTS SERVICES and its Financial Advisor, Bart Harrison. The lawsuit alleges that CONCORDE INVESTMENTS SERVICES and Bart Harrison understood […]

February 18, 2025
John Christoforidis Barred by FINRA Following Investigation

Financial Industry Regulatory Authority (FINRA) BrokerCheck reveals disclosures about securities broker John Christoforidis (CRD: 2841315, Garden City, New York). Christoforidis previously worked for multiple brokerage firms, including Spartan Capital Securities LLC from 2016 to 2024. Recent regulatory actions disclose that FINRA has barred Christoforidis from the securities industry following his refusal to provide on-the-record testimony […]

February 18, 2025
Joel Freedman Faces Allegations of Unauthorized Trading

Financial Industry Regulatory Authority (FINRA) BrokerCheck reveals disclosures about securities broker Joel Randy Freedman (CRD#: 1260557, Radnor, Pennsylvania). Freedman has been employed in the securities industry for 40 years and has worked with several firms, including Morgan Stanley (2009-2024). As of April 2024, he is registered with Sanctuary Securities Inc. and Sanctuary Advisors LLC in […]

Contact us Nationwide USA
2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062
Helping clients recover money across the USA
search
Copyright © 2022 Soreide Law Group, PLLC  |  All Rights Reserved